Bayer AG agreed on Thursday to pay $6.9 million to settle claims by New York Attorney General Letitia James that it misled consumers by advertising Roundup weedkiller as safe.
Bayer AG has reached a $6.9 million settlement with New York for allegedly making false and misleading claims regarding the safety of Roundup weedkillers, the state's Attorney General Letitia James sa

Perrigo hires Bayer's ex-U.S. head as new CEO

07:51am, Thursday, 08'th Jun 2023
Perrigo Co. Plc PRGO, +0.51% on Thursday named Patrick Lockwood-Taylor as its new president and chief executive officer as of June 30. Lockwood-Taylor previously worked in dual roles at Bayer AG as pr
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued. We share the heat map of the most investable candida
Bayer (BAYRY) announces licensing agreement with Cedilla Therapeutics to jointly develop and commercialize the latter's selective protein complex inhibitors as novel cancer therapies.
Bayer's (BAYRY) oral FXIa inhibitor, asundexian, gets the FDA's Fast Track Designation, as a preventive treatment for stroke and systemic embolism in people with atrial fibrillation.
Bayer (BAYRY) tops on first-quarter 2023 earnings but misses on sales. Management reiterates guidance.
European stock indices have done well in the past few months as the fear of a recession in the region have abated. In Germany, the DAX index jumped to €16,000, the highest point since January 2022.
Bayer stock is a textbook example of investing in a wonderful company at a fair price with an estimated upside potential between 30% - 120%. The group is suffering from a conglomerate discount and inv
Inflation and (expected) actions by the Federal Reserve continue to dominate market movements even though the turmoil in the financial sector shortly took center stage. Markets have started the new ye
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.
With 2-5 year U.S. Treasury securities currently yielding 3-4%, it makes great sense to search for equities that offer us both a competitive dividend with possible upside potential. Add to that divers
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.
Inflation and (expected) actions by the Federal Reserve continue to dominate market movements. Markets have started the new year with very solid gains following expectations about a more dovish Federa
Bayer (BAYRY) beats on earnings and sales in the fourth quarter. However, its 2023 outlook is dismal.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE